Skip to main content
. 2021 May 25;8(2):214–227. doi: 10.1093/ehjqcco/qcab028

Table 2.

Wald χ2, P-values, and hazard ratios for components of the GARFIELD-AF all-cause mortality model

All-cause mortality model χ 2 P-value Hazard ratio (95% CI)
Agea 956 <0.0001
 Up to 65 years 1.17 (1.11–1.23)
 65 years or older 1.38 (1.35–1.42)
Congestive heart failure 403 <0.0001 2.00 (1.87–2.14)
Ethnicity (ref.: Caucasian) 197 <0.0001
 Hispanic/Latino 1.17 (1.04–1.32)
 Asian 0.54 (0.49–0.60)
 Afro-Caribbean/Mixed/Other 1.46 (1.20–1.77)
Diastolic blood pressure (up to 80 mmHg)a 100 <0.0001 0.91 (0.89–0.93)
Weight (up to 75 kg)a 98 <0.0001 0.90 (0.88–0.92)
Pulse (up to 120 b.p.m.)a 96 <0.0001 1.04 (1.03–1.05)
Moderate-to-severe CKD 89 <0.0001 1.46 (1.35–1.58)
Treatment (ref.: no OAC) 89 <0.0001
 NOAC 0.66 (0.61–0.72)
 VKA 0.83 (0.77–0.90)
Vascular disease 74 <0.0001 1.36 (1.27–1.46)
Female sex 71 <0.0001 0.74 (0.69–0.79)
Diabetes 55 <0.0001 1.32 (1.23–1.43)
Dementia 40 <0.0001 1.63 (1.40–1.90)
Current smoker 36 <0.0001 1.41 (1.26–1.58)
History of bleeding 28 <0.0001 1.47 (1.27–1.70)
Prior stroke 26 <0.0001 1.31 (1.18–1.45)

CI, confidence interval; CKD, chronic kidney disease; NOAC, non-VKA oral anticoagulant; OAC, oral anticoagulation; VKA, vitamin K antagonist.

a

Hazard ratios with 95% CIs are based on incremental units of ‘5’.